Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Care Access is an active global clinical research organization specializing in decentralized and community-based trial delivery. It partners with leading biopharma companies to accelerate access to new medicines by operating over 200 permanent sites and more than 150 mobile health clinics. The company has supported over 300 trials across at least 14 therapeutic areas, including high-profile collaborations such as the BLAZE-2 Phase III COVID monoclonal antibody study with Eli Lilly. Its innovative model increases patient diversity and access by bringing research directly into communities through both physical sites and mobile units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Care Access.